Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:MRVCVE:NDVACVE:NRTHTSE:WLLW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMRVNuvo PharmaceuticalsC$0.00C$0.50▼C$1.55C$15.38M0.7827,569 shs6,732 shsNDVAIndivaC$0.03-14.3%C$0.03C$0.02▼C$0.13C$5.87M1.12119,038 shs558,384 shsNRTH48North CannabisC$0.07-6.7%C$0.07C$0.07▼C$0.42C$15.76MN/A708,229 shs152,117 shsWLLWWillow BiosciencesC$0.25-3.8%C$0.08C$0.01▼C$0.15C$36.21M1.13626,457 shs13,500 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMRVNuvo Pharmaceuticals0.00%0.00%0.00%0.00%0.00%NDVAIndiva0.00%0.00%0.00%0.00%0.00%NRTH48North Cannabis0.00%0.00%0.00%0.00%0.00%WLLWWillow Biosciences0.00%-16.67%+614.29%+4,900.00%+108.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMRVNuvo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ANDVAIndivaN/AN/AN/AN/AN/AN/AN/AN/ANRTH48North CannabisN/AN/AN/AN/AN/AN/AN/AN/AWLLWWillow BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMRVNuvo Pharmaceuticals 0.00N/AN/AN/ANDVAIndiva 0.00N/AN/AN/ANRTH48North Cannabis 0.00N/AN/AN/AWLLWWillow Biosciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMRVNuvo PharmaceuticalsC$72.42M0.00N/A0.23C$0.75 per share0.00NDVAIndivaC$37.57M0.16C$0.01 per share5.20N/A∞NRTH48North CannabisC$18.90M0.83C$0.01 per share8.75C$0.15 per share0.47WLLWWillow BiosciencesC$2.94M12.30C$0.30 per share0.83C$0.00 per share180.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMRVNuvo PharmaceuticalsC$15.17M-C$0.07N/AN/AN/A20.95%1,180.47%5.85%N/ANDVAIndiva-C$4.92M-C$0.03N/A∞N/A-13.09%-544.76%-3.51%N/ANRTH48North CannabisN/A-C$0.23N/A∞N/AN/AN/AN/AN/AWLLWWillow Biosciences-C$7.92M-C$0.05N/A∞N/A-268.91%-602.73%-74.79%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMRVNuvo PharmaceuticalsN/AN/AN/AN/AN/ANDVAIndivaN/A4.04%N/AN/AN/ANRTH48North CannabisN/AN/AN/AN/AN/AWLLWWillow BiosciencesN/A7.35%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMRVNuvo Pharmaceuticals1,165.852.111.68NDVAIndiva5,899.220.720.52NRTH48North Cannabis18.281.290.34WLLWWillow Biosciences902.050.8019.71Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMRVNuvo Pharmaceuticals17.71%NDVAIndiva0.06%NRTH48North CannabisN/AWLLWWillow Biosciences0.10%Insider OwnershipCompanyInsider OwnershipMRVNuvo Pharmaceuticals6.32%NDVAIndiva36.29%NRTH48North CannabisN/AWLLWWillow Biosciences24.34%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMRVNuvo PharmaceuticalsN/A11.39 millionN/ANot OptionableNDVAIndiva147,000195.49 millionN/ANot OptionableNRTH48North Cannabis47225.17 millionN/ANot OptionableWLLWWillow Biosciences19144.85 millionN/ANot OptionableNDVA, WLLW, NRTH, and MRV HeadlinesRecent News About These CompaniesWILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF TRANSFORMATIVE RECAPITALIZATION TRANSACTIONS TO FORM ATLAS ENERGY CORP.June 19, 2025 | finance.yahoo.comWILLOW BIOSCIENCES INC. ANNOUNCES CONDITIONAL ACCEPTANCE OF TSX VENTURE EXCHANGE TO LIST PURSUANT TO THE TSXV SANDBOXJune 18, 2025 | stockhouse.comWillow Biosciences Inc.: Willow Biosciences Reports First Quarter 2025 Financial ResultsMay 13, 2025 | finanznachrichten.deWILLOW BIOSCIENCES INC. RECEIVES FIRM COMMITMENTS OF $30.0 MILLION UNDER PREVIOUSLY ANNOUNCED RECAPITALIZATION FINANCINGMay 9, 2025 | finance.yahoo.comWillow Biosciences Inc.: Willow Biosciences Announces Annual General And Special Meeting Voting ResultsApril 26, 2025 | finanznachrichten.deWillow Biosciences reports significant loss and imminent closureMarch 27, 2025 | msn.comWillow Biosciences to sell operating subsidiary Epimeron USA Inc.March 17, 2025 | msn.comWillow Biosciences to sell operating subsidiary for $3.38MMarch 17, 2025 | greenmarketreport.comGWILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARYMarch 15, 2025 | finance.yahoo.comWillow Biosciences is looking for a buyerJanuary 21, 2025 | greenmarketreport.comGWILLOW ANNOUNCES CANCELLATION OF PREVIOUSLY ANNOUNCED NON-BROKERED OFFERING TO PURSUE LESS DILUTIVE ALTERNATIVESJanuary 2, 2025 | finance.yahoo.comWillow Biosciences Third Quarter 2024 Earnings: CA$0.01 loss per share (vs CA$0.018 loss in 3Q 2023)November 15, 2024 | finance.yahoo.comWillow Biosciences Inc.: Willow Biosciences Reports Third Quarter 2024 Financial Results And Provides Corporate UpdateNovember 12, 2024 | finanznachrichten.deWLLW:CA Willow Biosciences Inc.September 10, 2024 | seekingalpha.comCBG Producer Willow Biosciences Reports Record Q2 Revenue, Enters Major Pharma Deal Slated To Be Key Driver Of GrowthAugust 12, 2024 | benzinga.comWillow Biosciences Inc.August 9, 2024 | baystreet.caWILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITSJuly 19, 2024 | finance.yahoo.comClosing Bell: Willow Biosciencesinc flat on Monday (WLLW)May 16, 2024 | theglobeandmail.comTSX:WLLW (Willow Biosciences Inc.)April 18, 2024 | fool.caWillow Biosciences Inc (WLLW)April 9, 2024 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNDVA, WLLW, NRTH, and MRV Company DescriptionsNuvo Pharmaceuticals TSE:MRVNuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada.Indiva CVE:NDVAC$0.03 -0.01 (-14.29%) As of 06/12/2024Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.48North Cannabis CVE:NRTHC$0.07 -0.01 (-6.67%) As of 09/2/202148North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada.Willow Biosciences TSE:WLLWC$0.25 -0.01 (-3.85%) As of 07/4/2025Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
